Delivery Order SPE2DB24D6041-SPE2DB25FKBKT

Award Date 11/15/24
Potential Completion Date 11/18/24
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award is for the delivery of Methylphenidate ER (long-acting) 30mg capsules, awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, by the Defense Logistics Agency (DLA). The $1,778.85 delivery order contract is a firm fixed-price contract with no set-aside designation, indicating open competition. AmerisourceBergen, a subsidiary of the parent company Cencora, Inc., holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp for the delivery of 4,566,370,660 units of methylphenidate ER 18 mg tablets. The firm-fixed-price delivery order, valued at $5,038.82, has an ultimate completion date of November 8, 2024. The contract is not designated as a set-aside. AmerisourceBergen, a major pharmaceutical distributor, has an Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical worth $999,999,999...
This federal contract award is for the delivery of 4,566,639,713 units of Methylphenidate ER 36 mg tablets, a prescription medication, to the Defense Logistics Agency (DLA) Troop Support Medical. The $1,535.37 firm fixed-price delivery order was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract has an ultimate completion date of December 9, 2024. Amerisourcebergen is a for-profit organization registered in the System for...
This federal contract award is for the delivery of 4,564,730,093 units of methylphenidate LA 20 mg capsules in bottles of 100 to the Defense Logistics Agency (DLA). The $1,281.18 firm fixed price delivery order was awarded to Amerisourcebergen Drug Corp's Corporate Office Division on May 28, 2024 with a completion date of May 29, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a $999,999,999.00 single-award Indefinite Delivery Contract (IDC) with DLA Troop Support...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $1,171.28 Firm Fixed Price Delivery Order covers the supply of 4,564,662,470 units of Methylphenidate ER (LA) 30mg Capsules, with a period of performance through May 21, 2024. The contract is not designated as a set-aside. AmerisourceBergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the...
This federal contract award is for the delivery of 4,564,994,948 units of the prescription drug Methylphenidate ER 36 mg tablets to the Defense Logistics Agency (DLA), a component of the Department of Defense (DoD). The $1,606.50 firm fixed-price contract was awarded to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, through the company's Corporate Office division. The contract has an ultimate completion date of June 26, 2024 and does not have a set-aside designation....
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of 4,567,557,327 units of Methylphenidate ER (long-acting) 10mg capsules, with a total ceiling value of $1,188.90. The contract is a Firm Fixed Price Delivery Order, with a period of performance ending on March 12, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract...
This federal contract award is for the delivery of 4,566,529,495 units of Methylphenidate Extended-Release (30mg capsules) to the Defense Logistics Agency (DLA). The $1,352.51 firm fixed-price contract was awarded to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, on November 22, 2024 with a completion date of November 25, 2024. The contract is a delivery order under AmerisourceBergen's existing Indefinite Delivery Contract (IDC) with the DLA, valued at $999,999,999 and...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of 4,564,960,182 units of Methylphenidate LA 40 mg capsules in 100-count bottles. The $2,930.62 firm-fixed-price delivery order was issued by the Defense Logistics Agency (DLA), a defense agency, with a completion date of June 21, 2024. Amerisourcebergen holds a $999,999,999.00 Indefinite Delivery Contract (IDC) with DLA Troop Support Medical, which serves as the primary vehicle for the...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division, a subsidiary of Amerisourcebergen Corporation, is for the delivery of 4,564,557,576 units of Methylphenidate ER 36 mg tablets in packages of 100. The $1,707.16 firm fixed-price contract was awarded by the Defense Logistics Agency (DLA), a defense agency, on May 9, 2024, with a completion date of May 10, 2024. Amerisourcebergen holds a large Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
  • SPE2DB24D6041
    Indefinite Delivery Contract
  • SPE2DB24D6041-SPE2DB25FKBKT
    Delivery Order

This federal contract award is for the delivery of 4,566,443,540 units of Methylphenidate ER (long-acting) 30mg capsules, placed by the Defense Logistics Agency (DLA) with Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $1,087.96 firm fixed-price delivery order has a completion date of November 18, 2024. Amerisourcebergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical through November 2026, covering a wide range of pharmaceutical products and medical supplies for military healthcare programs. The company also maintains a separate $750,000 IDC with the Department of Justice Federal Bureau of Investigation for similar medical commodities. None of the contract awards reviewed were designated with set-aside requirements, indicating open competition.

Generated 2/14/25, 9:33 AM